S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)

Veru (VERU) News Today

$0.72
-0.04 (-5.26%)
(As of 12/29/2023 ET)
SourceHeadline
finance.yahoo.com logoVeru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Loss Associated with Weight Loss GLP-1 Drugs
finance.yahoo.com - December 19 at 10:15 AM
finance.yahoo.com logoThe Price Is Right For Veru Inc. (NASDAQ:VERU) Even After Diving 29%
finance.yahoo.com - December 18 at 8:23 AM
tmcnet.com logoVERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
tmcnet.com - December 14 at 10:40 PM
msn.com logoVeru stock falls after it prices its public offering at $0.72 per share
msn.com - December 14 at 12:40 PM
nj.com logoMets address signing free agent who endured ‘bad luck’
nj.com - December 5 at 2:30 PM
msn.com logoLuton Town back Bedfordshire Police's knife crime campaign
msn.com - November 23 at 7:56 AM
finance.yahoo.com logoVeru Inc. (VERU) Stock Historical Prices & Data - Yahoo Finance
finance.yahoo.com - November 11 at 7:57 AM
finance.yahoo.com logoThe past year for Veru (NASDAQ:VERU) investors has not been profitable
finance.yahoo.com - November 10 at 10:51 AM
benzinga.com logoVERU INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Veru Inc. - VERU
benzinga.com - October 16 at 3:56 PM
msn.com logoTandridge restaurant given new food hygiene rating
msn.com - October 13 at 7:52 AM
ca.finance.yahoo.com logoVeru Inc. (VERU)
ca.finance.yahoo.com - October 6 at 12:54 AM
markets.businessinsider.com logoPromising Drug Development Pipeline Bolsters Buy Rating for Veru: Enobosarm’s Potential and Upcoming Trials in Focus
markets.businessinsider.com - October 5 at 9:53 AM
msn.com logoVeru to conduct Phase2b study with enobosarm, GLP-1 weight-loss drugs
msn.com - October 4 at 1:41 PM
finance.yahoo.com logoVeru Reports Muscle Data from 5 Clinical Studies of Enobosarm that Support the Advancement of Enobosarm in Combination with Weight-Loss GLP-1 Drugs, Ozempic®, Wegovy®, or Mounjaro®, to Optimize Weight Loss by Preventing Muscle Wasting and Further Increasing Fat Loss in a Phase 2b Obesity Clinical Study
finance.yahoo.com - October 4 at 8:41 AM
markets.businessinsider.com logoPromising Drug Developments Bolster Veru’s Buy Rating: An Analysis of Sabizabulin and Enobosarm Trials
markets.businessinsider.com - September 27 at 7:42 AM
finance.yahoo.com logoVeru Reaches Agreement with FDA on New Phase 3 Clinical Trial for Sabizabulin for Broader Indication: Hospitalized Adult Patients with Any Type of Viral Acute Respiratory Distress Syndrome (ARDS)
finance.yahoo.com - September 26 at 10:28 AM
finance.yahoo.com logoVeru to Participate in Fireside Chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on September 28th, 2023
finance.yahoo.com - September 20 at 9:24 AM
finance.yahoo.com logoVeru Reports Clinical Data from the Discontinued ARTEST Study of Enobosarm, Novel Selective Androgen Receptor Targeting Agonist, in AR+ ER+ HER2- Metastatic Breast Cancer
finance.yahoo.com - September 11 at 6:53 PM
finance.yahoo.com logoVeru to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 11th, 2023
finance.yahoo.com - August 30 at 8:36 AM
msn.com logoVeru: Stocks are being driven down by high valuations despite strong earnings
msn.com - August 28 at 12:43 PM
finance.yahoo.com logoVeru Inc. (NASDAQ:VERU) Analysts Just Trimmed Their Revenue Forecasts By 25%
finance.yahoo.com - August 16 at 7:18 AM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on Veru (VERU)
markets.businessinsider.com - August 14 at 2:10 PM
finance.yahoo.com logoWhat You Can Learn From Veru Inc.'s (NASDAQ:VERU) P/S
finance.yahoo.com - August 11 at 5:09 PM
msn.com logoVeru GAAP EPS of $0.07 beats by $0.27, revenue of $3.34M misses by $6.88M
msn.com - August 10 at 9:31 AM
finance.yahoo.com logoVeru Reports Fiscal 2023 Third Quarter Financial Results
finance.yahoo.com - August 10 at 9:31 AM
finance.yahoo.com logoVeru to Report Fiscal 2023 Third Quarter Financial Results on August 10, 2023
finance.yahoo.com - August 3 at 12:25 PM
msn.com logoBaby Movie Review: An odious, operatic tragedy of errors
msn.com - August 1 at 2:46 PM
msn.com logoStay Away From Veru Until 2024
msn.com - July 20 at 6:09 PM
cnbc.com logoVeru: Markets don't appreciate the rapid change in liquidity conditions
cnbc.com - July 10 at 7:41 AM
finance.yahoo.com logoVeru Inc.’s Oncology Drug Research Program Partner, The University of Tennessee Health Science Center, Awarded Two New Federal Grants
finance.yahoo.com - June 21 at 1:29 PM
marketbeat.com logo98,255 Shares in Veru Inc. (NASDAQ:VERU) Bought by ETF Managers Group LLC
marketbeat.com - June 19 at 5:24 AM
msn.com logoJefferies Upgrades Veru (VERU)
msn.com - June 7 at 9:22 PM
msn.com logoJefferies upgrades Veru to hold, cites upcoming breast cancer study data
msn.com - June 7 at 4:22 PM
markets.businessinsider.com logo6 Analysts Have This to Say About Veru
markets.businessinsider.com - June 7 at 4:22 PM
markets.businessinsider.com logoWhat 6 Analyst Ratings Have To Say About Veru
markets.businessinsider.com - June 7 at 10:38 AM
finance.yahoo.com logoVeru Announces Appointment of Dr. Erik Swenson and Dr. Robert Schooley to its Infectious Disease Scientific Advisory Board
finance.yahoo.com - June 1 at 9:53 AM
finance.yahoo.com logoVeru to Present at the Jefferies Healthcare Conference
finance.yahoo.com - May 24 at 8:58 AM
msn.com logoHC Wainwright & Co. Maintains Veru (VERU) Buy Recommendation
msn.com - May 15 at 4:58 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Veru (VERU)
markets.businessinsider.com - May 15 at 8:36 AM
finanznachrichten.de logoVeru Inc.: Veru Reports Fiscal 2023 Second Quarter Financial Results
finanznachrichten.de - May 12 at 8:49 PM
msn.com logoVeru Q2: Revenue Halves, Prioritizes Clinical Programs, Wider Loss & More
msn.com - May 12 at 10:49 AM
finance.yahoo.com logoVeru Inc. (VERU) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - May 11 at 1:35 PM
msn.com logoVeru: Q2 Earnings Insights
msn.com - May 11 at 8:34 AM
markets.businessinsider.com logoVERU Stock Earnings: Veru Misses EPS, Beats Revenue Estimates
markets.businessinsider.com - May 11 at 8:34 AM
finance.yahoo.com logoVeru Reports Fiscal 2023 Second Quarter Financial Results
finance.yahoo.com - May 11 at 8:34 AM
markets.businessinsider.com logoAnalyst Ratings for Veru
markets.businessinsider.com - May 10 at 3:55 PM
msn.com logoA Preview Of Veru's Earnings
msn.com - May 10 at 3:55 PM
msn.com logoVeru Q2 2023 Earnings Preview
msn.com - May 10 at 3:55 PM
finance.yahoo.com logoIs a Surprise Coming for Veru (VERU) This Earnings Season?
finance.yahoo.com - May 9 at 3:10 PM
finance.yahoo.com logoVeru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin Treatment of Hospitalized COVID-19 Adult Patients at High Risk for ARDS
finance.yahoo.com - May 4 at 1:26 PM
Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.



VERU Media Mentions By Week

VERU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VERU
News Sentiment

1.89

0.84

Average
Medical
News Sentiment

VERU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VERU Articles
This Week

1

1

VERU Articles
Average Week

Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:VERU) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -